The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Three Arch Associates Iv Lp since 2012.
The trader's CIK number is 1276986.
At the time of the last reporting, Three Arch Associates Iv Lp was the 10% Owner of Concert Pharmaceuticals, Inc.. (stock ticker symbol CNCE).
Also see all insider trading activities at Concert Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CNCE | 0 | $0 | 250,000 | $3,072,500 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | ACRX | 2,416,918 | $7,999,998 | 0 | $0 | 0 | $0 |
1. Concert Pharmaceuticals, Inc. (CNCE)
2. Acelrx Pharmaceuticals Inc (ACRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-11-18 | CNCE | Sale | 250,000 | 12.29 | 3,072,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-12-07 | ACRX | Buy | 2,416,918 | 3.31 | 7,999,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Three Arch Associates Iv Lp (10% Owner of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.